10 stories found
Tandem Diabetes Care has detailed its strategic plans, including a shift in its pharmacy operations, targeting a 65% gross margin, and announcing the planned launch of its Mobi Tubeless product in 2026.
The Brown Capital Management Small Company Fund has reportedly sold its shares in Tandem Diabetes Care (TNDM), with reasons for the divestment being explored.
Tandem Diabetes Care, Inc. summarized its financial performance during its Q4 2025 earnings call.
Tandem Diabetes shares have increased after the company reported better-than-expected fourth-quarter earnings.
Tandem Diabetes Care has announced the pricing of its $265 million convertible debt offering.
Analysts have provided insights on several healthcare companies, including Integer Holdings (ITGR), Spyre Therapeutics (SYRE), and Tandem Diabetes Care (TNDM).
Tandem Diabetes Care aims for a 10-11% growth in pump shipments by 2026, driven by its transition to a PayGo model.
Tandem Diabetes Care has announced a proposed private placement of convertible notes.
Weave Communications' stock saw a notable drop on Friday, prompting analysis into the reasons behind its performance.
Tandem Diabetes Care's Q4 earnings call presented the company's financial performance and strategic initiatives.